Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma

被引：37
作者：
Hill, Brian T. [1 ]
Roberts, Zachary J. [2 ]
Xue, Allen [2 ]
Rossi, John M. [2 ]
Smith, Mitchell R. [1 ,3 ]
机构：
[1] Cleveland Clin Fdn, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Kite, Santa Monica, CA USA
[3] George Washington Canc Ctr, Washington, DC USA
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / 06期
关键词：
D O I：
10.1038/s41409-019-0657-3
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1184 / 1187
页数：4
相关论文
共 14 条
  • [1] [Anonymous], 2017, YESC AX CIL PACK INS
  • [2] [Anonymous], BLOOD
  • [3] Revised response criteria for malignant lymphoma
    Cheson, Bruce D.
    Pfistner, Beate
    Juweid, Malik E.
    Gascoyne, Randy D.
    Specht, Lena
    Horning, Sandra J.
    Coiffier, Bertrand
    Fisher, Richard I.
    Hagenbeek, Anton
    Zucca, Emanuele
    Rosen, Steven T.
    Stroobants, Sigrid
    Lister, T. Andrew
    Hoppe, Richard T.
    Dreyling, Martin
    Tobinai, Kensei
    Vose, Julie M.
    Connors, Joseph M.
    Federico, Massimo
    Diehl, Volker
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 579 - 586
  • [4] PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR
    Chong, Elise A.
    Melenhorst, J. Joseph
    Lacey, Simon F.
    Ambrose, David E.
    Gonzalez, Vanessa
    Levine, Bruce L.
    June, Carl H.
    Schuster, Stephen J.
    [J]. BLOOD, 2017, 129 (08) : 1039 - 1041
  • [5] Characterization of anti-CD19 chimeric antigen receptor (CAR) T cell-mediated tumor microenvironment immune gene profile in a multicenter trial (ZUMA-1) with axicabtagene ciloleucel (axi-cel, KTE-C19).
    Galon, Jerome
    Rossi, John
    Turcan, Sarah
    Danan, Corinne
    Locke, Frederick Lundry
    Neelapu, Sattva Swarup
    Miklos, David Bernard
    Bartlett, Nancy L.
    Jacobson, Caron Alyce
    Braunschweig, Ira
    Oluwole, Olalekan O.
    Siddiqi, Tanya
    Lin, Yi
    Timmerman, John
    Reagan, Patrick Michael
    Lekakis, Lazaros J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
    Kochenderfer, James N.
    Somerville, Robert P. T.
    Lu, Tangying
    Shi, Victoria
    Bot, Adrian
    Rossi, John
    Xue, Allen
    Goff, Stephanie L.
    Yang, James C.
    Sherry, Richard M.
    Klebanoff, Christopher A.
    Kammula, Udai S.
    Sherman, Marika
    Perez, Arianne
    Yuan, Constance M.
    Feldman, Tatyana
    Friedberg, Jonathan W.
    Roschewski, Mark J.
    Feldman, Steven A.
    McIntyre, Lori
    Toomey, Mary Ann
    Rosenberg, Steven A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) : 1803 - 1813
  • [7] Current concepts in the diagnosis and management of cytokine release syndrome
    Lee, Daniel W.
    Gardner, Rebecca
    Porter, David L.
    Louis, Chrystal U.
    Ahmed, Nabil
    Jensen, Michael
    Grupp, Stephan A.
    Mackall, Crystal L.
    [J]. BLOOD, 2014, 124 (02) : 188 - 195
  • [8] Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
    Lesokhin, Alexander M.
    Ansell, Stephen M.
    Armand, Philippe
    Scott, Emma C.
    Halwani, Ahmad
    Gutierrez, Martin
    Millenson, Michael M.
    Cohen, Adam D.
    Schuster, Stephen J.
    Lebovic, Daniel
    Dhodapkar, Madhav
    Avigan, David
    Chapuy, Bjoern
    Ligon, Azra H.
    Freeman, Gordon J.
    Rodig, Scott J.
    Cattry, Deepika
    Zhu, Lili
    Grosso, Joseph F.
    Garelik, M. Brigid Bradley
    Shipp, Margaret A.
    Borrello, Ivan
    Timmerman, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2698 - +
  • [9] Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
    Locke, Frederick L.
    Ghobadi, Armin
    Jacobson, Caron A.
    Miklos, David B.
    Lekakis, Lazaros J.
    Oluwole, Olalekan O.
    Lin, Yi
    Braunschweig, Ira
    Hill, Brian T.
    Timmerman, John M.
    Deol, Abhinav
    Reagan, Patrick M.
    Stiff, Patrick
    Flinn, Ian W.
    Farooq, Umar
    Goy, Andre
    McSweeney, Peter A.
    Munoz, Javier
    Siddiqi, Tanya
    Chavez, Julio C.
    Herrera, Alex F.
    Bartlett, Nancy L.
    Wiezorek, Jeffrey S.
    Navale, Lynn
    Xue, Allen
    Jiang, Yizhou
    Bot, Adrian
    Rossi, John M.
    Kim, Jenny J.
    Go, William Y.
    Neelapu, Sattva S.
    [J]. LANCET ONCOLOGY, 2019, 20 (01) : 31 - 42
  • [10] Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
    Locke, Frederick L.
    Neelapu, Sattva S.
    Bartlett, Nancy L.
    Siddiqi, Tanya
    Chavez, Julio C.
    Hosing, Chitra M.
    Ghobadi, Armin
    Budde, Lihua E.
    Bot, Adrian
    Rossi, John M.
    Jiang, Yizhou
    Xue, Allen X.
    Elias, Meg
    Aycock, Jeff
    Wiezorek, Jeff
    Go, William Y.
    [J]. MOLECULAR THERAPY, 2017, 25 (01) : 285 - 295
12